Advertisement

Topics

Lonza Group Ltd Company Profile

12:39 EST 10th December 2018 | BioPortfolio

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality-minded production. Creative thinking, dedicated staff and sound resources are the strengths that Lonza relies on for further growth. Our people are the key to success – they have extensive expertise in multidisciplinary project management, integrating the wishes and know-how of our customers at every stage.

Location

Muenchensteinerstrasse 38
Basel
CH-4002
Switzerland

Contact

Phone: 41 61 316 81 11
Fax: 41 61 316 91 11
Email: info@lonza.com


News Articles [762 Associated News Articles listed on BioPortfolio]

Lonza and Sartorius Modify Relationship for Supply of Cell Culture Media

NewsSartorius Stedim Biotech, as a preferred supplier for equipment and consumables, will continue to offer Lonza media and buffer products, but under a non-exclusive agreement.

Lonza Group Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

Lonza Group Ltd Strategy, SWOT and Corporate Finance ReportSummaryLonza Group Ltd Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report c...

Lonza Expands Capabilities for Parenteral Dosage Forms

NewsThe expanded offering includes new capabilities for clinical administration, lyophilization cycle and process development, and device functionality testing.

Lonza to Divest Water Care Business for $630M

NewsThe company's strategic focus will remain on three core healthcare pillars: Pharma & Biotech, Consumer Health, and Consumer & Resources Protection.

Lonza Unit Launches Colorista Capsule to Cut Down on Development Time

NewsCapsugel Colorista capsules allow for flexibility to progress with technical development before the final commercial color decision is taken.

Lonza sells water care business to focus on healthcare

Lonza and Platinum Equity jointly announced today that Platinum Equity has entered into a definitive agreement with Lonza to acquire Lonza's Water Care business and operations for USD 630 million. The...

Lonza Group AG: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media

Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive ag...

Lonza to establish China base through GE Healthcare partnership

Biotechnology company Lonza has announced an initiative with GE Healthcare in which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou, China (CN).

PubMed Articles [1742 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4104 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

The T2T Study of RA Based on SSDM

This study evaluate the Smart System of Disease Management(SSDM)to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be ...

Companies [1644 Associated Companies listed on BioPortfolio]

LONZA Biologics plc

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality...

Lonza Group Ltd

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality...

Lonza Inc.

Basel, 17.05.2006 - Lonza Group announces the acquisition of assets which comprise Larex, Inc.’s Larch Arabinogalactan business. This strategic acquisition includes among other things, intellectual...

Akouos

Akouos is a precision genetic medicine company developing gene therapies that restore and preserve hearing. Leveraging its adeno-associated viral vectors (AAV)-based gene therapy ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

More Information about "Lonza Group Ltd" on BioPortfolio

We have published hundreds of Lonza Group Ltd news stories on BioPortfolio along with dozens of Lonza Group Ltd Clinical Trials and PubMed Articles about Lonza Group Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lonza Group Ltd Companies in our database. You can also find out about relevant Lonza Group Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record